Track the HLS stock price and the full management transaction log of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, HLS has published 11 reports. Market capitalisation: €67.4m. The latest transaction was disclosed on 8 September 2026 (Initial Substantial Holding). Among the most active insiders: its controlled bodies corporate listed in Annexure A. Every trade is free.
11
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 16,182 of 29,063 companies
48.9
score / 100
Value
60
Quality
38
FCF yld23%
Earn yld-18%
EV/EBITDA7.3x
ROE-14%
Gross mgn82%
Net mgn-22%
Debt/EBITDA3.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
HLS es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XASX. Se centra en el desarrollo y la comercialización de soluciones innovadoras para el campo médico.